Topiramate in migraine prophylaxis: An open-label extension of a double-blind, placebo-controlled study

被引：0
|
作者：
Hart, DE
Calder, CS
Storey, JR
Riback, P
Potter, DL
Wymer, JP
Beesley, BA
机构：
来源：
NEUROLOGY | 2002年 / 58卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A496 / A497
页数：2
相关论文
共 50 条
  • [41] LONG-ACTING PROPRANOLOL IN MIGRAINE PROPHYLAXIS - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    PRADALIER, A
    SERRATRICE, G
    COLLARD, M
    HIRSCH, E
    FEVE, J
    MASSON, M
    MASSON, C
    DRY, J
    KOULIKOVSKY, G
    NGUYEN, G
    SCHBATH, J
    CARPENTIER, MC
    CEPHALALGIA, 1989, 9 (04) : 247 - 253
  • [42] Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension
    Smith-Apeldoorn, Sanne Y.
    Veraart, Jolien K. E.
    Kamphuis, Jeanine
    Spijker, Jan
    van der Meij, Annemarie
    van Asselt, Antoinette D. I.
    aan het Rot, Marije
    Schoevers, Robert A.
    MOLECULAR PSYCHIATRY, 2024, 29 (09) : 2657 - 2665
  • [43] Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
    Lesley M. Arnold
    Kenneth N. Schikler
    Lucinda Bateman
    Tahira Khan
    Lynne Pauer
    Pritha Bhadra-Brown
    Andrew Clair
    Marci L. Chew
    Joseph Scavone
    Pediatric Rheumatology, 14
  • [44] SAFETY AND EFFICACY OF INCOBOTULINUMTOXINA FOR THE TREATMENT OF UPPER FACIAL LINES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY WITH OPEN-LABEL EXTENSION
    Trevidic, Patrick
    Connolly, Simon A.
    Biwer, Bernard
    Weissenberger, Petra
    Kestemont, Philippe
    Noah, Ernst M.
    Sattler, Gerhard
    Kerscher, Martina
    TOXICON, 2018, 156 : S110 - S110
  • [45] Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
    Arnold, Lesley M.
    Schikler, Kenneth N.
    Bateman, Lucinda
    Khan, Tahira
    Pauer, Lynne
    Bhadra-Brown, Pritha
    Clair, Andrew
    Chew, Marci L.
    Scavone, Joseph
    PEDIATRIC RHEUMATOLOGY, 2016, 14
  • [46] Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study
    Takashi Wada
    Masaya Inagaki
    Toru Yoshinari
    Ryuji Terata
    Naoko Totsuka
    Miki Gotou
    Gaia Hashimoto
    Clinical and Experimental Nephrology, 2021, 25 : 120 - 130
  • [47] A Double-Blind, Placebo-Controlled Trial of Topiramate for Pathological Gambling
    Berlin, Heather A.
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 37S - 37S
  • [48] A double-blind, placebo-controlled trial of topiramate for pathological gambling
    Berlin, Heather A.
    Braun, Ashley
    Simeon, Daphne
    Koran, Lorrin M.
    Potenza, Marc N.
    McElroy, Susan L.
    Fong, Timothy
    Pallanti, Stefano
    Hollander, Eric
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2013, 14 (02): : 121 - 128
  • [49] A double-blind placebo-controlled trial of Topiramate for essential tremor
    Tarsy, D
    Apetauerova, D
    Griffith, AF
    Press, DZ
    Ryan, P
    Wu, CS
    MOVEMENT DISORDERS, 2002, 17 : S342 - S343
  • [50] Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
    Silberstein, Stephen D.
    Lipton, Richard B.
    Dodick, David W.
    Freitag, Frederick G.
    Ramadan, Nabih
    Mathew, Ninan
    Brandes, Jan L.
    Bigal, Marcelo
    Saper, Joel
    Ascher, Steven
    Jordan, Donna M.
    Greenberg, Steven J.
    Hulihan, Joseph
    HEADACHE, 2007, 47 (02): : 170 - 180
12345